Source: Annual Congress 2010 - Immune modulation of airways diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Dehzad, C. Tertilt, G. Gyuelveszi, K. Kreymborg, K. Schneeweiß, E. Michel, S. Reuter, H. Martin, J. C. Renauld, R. Buhl, B. Becher, C. Taube (Mainz, Germany; Zurich, Switzerland; Louvain, Belgium). IL-22 as a negative regulator of allergic airway disease. Eur Respir J 2010; 36: Suppl. 54, 1921

Member's Comments

No comment yet.

Related content which might interest you: The inflammation and the airway hyperresponsiveness in allergic asthma is inhibited by IL-10 dependent mechanism Source: Annual Congress 2007 - Mouse models of allergic airway inflammation Year: 2007 ILC2s in allergic airway inflammation Source: International Congress 2014 – Highlights from the Lung Science Conference 2014 Year: 2014 GATA-3 or T-bet: Who is the crucial marker of allergic bronchial asthma Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011 Farm dust decreases Th2 driven allergic airway inflammation in mice: A role for airway TLR2 and TLR4? Source: Annual Congress 2011 - T-cell subsets Year: 2011 A potential role of P2X7R in allergic airway inflammation Source: Annual Congress 2010 - Asthma: basic science and clinical studies Year: 2010 The effect of Der f-induced airway inflammation on airway inflammation in a murine model of allergic asthma Source: Eur Respir J 2004; 24: Suppl. 48, 348s Year: 2004 Role of IL-33 signaling in pollutant-induced allergic airway inflammation Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases Year: 2018 IL-33 mRNA in induced sputum cells from allergic rhinitis and asthma patients: a marker of Th-2 phenotype status? Source: International Congress 2017 – Monitoring asthma control Year: 2017 High-level expression of PD-L1 by DC suppresses airway inflammation in OVA-induced allergic asthma Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 The role of MKK3 in allergic and non-allergic inflammatory responses in the lung Source: Annual Congress 2011 - Immunology and cell biology of asthma and COPD Year: 2011 The airway inflammatory response in allergic mice is downregulated by budesonide Source: Eur Respir J 2001; 18: Suppl. 33, 265s Year: 2001 A dual role of IL-6 signalling and STAT-3 activation on airway inflammation versus airway hyperresponsiveness in a murine model of asthma Source: Eur Respir J 2002; 20: Suppl. 38, 568s Year: 2002 CCL6 produced by eosinophils drives allergic airway inflammation in mice Source: International Congress 2019 – Modelling and monitoring of airway diseases Year: 2019 IL-17F, rather than IL-17A, underlies airway inflammation in a steroid-insensitive toluene diisocyanate-induced asthma model Source: Eur Respir J, 53 (4) 1801510; 10.1183/13993003.01510-2018 Year: 2019 Sputum CC-chemokines, IL-13 and pulmonary function in allergic asthmatic children Source: Eur Respir J 2004; 24: Suppl. 48, 396s Year: 2004 Rhinitis, nasal polyposis and asthma: pathological aspects Source: ISSN=1025-448x, ISBN=1-904097-19-18, page=115 Year: 2001 Imiquimod attenuate airway inflammation and decrease the expression of TARC in allergic asthmatic mice Source: Eur Respir J 2006; 28: Suppl. 50, 224s Year: 2006 P-selectin expression in chronic allergic airway inflammation Source: Eur Respir J 2001; 18: Suppl. 33, 271s Year: 2001 Analysis of airway inflammation in allergic subjects with asymptomatic increased airway response to methacholine Source: Eur Respir J 2006; 28: Suppl. 50, 678s Year: 2006